ACCELERATING THE DEVELOPMENT OF NOVEL ANTIBODY-DRUG CONJUGATES THROUGH SITE-SPECIFIC CONJUGATION METHODS

BACKGROUND: Antibody–drug conjugates (ADC) typically consist of a monoclonal antibody (mAbs) attached to a cytotoxic payload via a chemical linker. ADC development requires careful consideration of each of its key components and development strategy since each element has the potential to affect the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouyang, An, Chiang, Spencer, Wang, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370430/
http://dx.doi.org/10.1093/abt/tbad014.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370430/
http://dx.doi.org/10.1093/abt/tbad014.021

Ejemplares similares